|
ACETAZOLAMIDE POTENTIATES THE EFFECTS OF FOLIC ACID ANTAGONISTS
|
ACETAZOLAMIDE POTENTIATES THE EFFECTS OF FOLIC ACID ANTAGONISTS
|
ACETAZOLAMIDE POTENTIATES THE EFFECTS OF FOLIC ACID ANTAGONISTS
|
ACETAZOLAMIDE POTENTIATES THE EFFECTS OF FOLIC ACID ANTAGONISTS
|
ACETAZOLAMIDE POTENTIATES THE EFFECTS OF FOLIC ACID ANTAGONISTS
|
ACETAZOLAMIDE POTENTIATES THE EFFECTS OF FOLIC ACID ANTAGONISTS
|
ACETAZOLAMIDE POTENTIATES THE EFFECTS OF FOLIC ACID ANTAGONISTS
|
ACETAZOLAMIDE POTENTIATES THE EFFECTS OF FOLIC ACID ANTAGONISTS
|
ACETAZOLAMIDE POTENTIATES THE EFFECTS OF FOLIC ACID ANTAGONISTS
|
ACETAZOLAMIDE POTENTIATES THE EFFECTS OF FOLIC ACID ANTAGONISTS
|
ACETAZOLAMIDE POTENTIATES THE EFFECTS OF FOLIC ACID ANTAGONISTS
|
NITROFURANTOIN ACTIVITY IS REDUCED IN THE PRESENCE OF CARBONIC ANHYDRASE INHIBITORS & OTHER DRUGS THAT ALKALINISE URINE
|
CO-ADMINISTRATION MAY LEAD TO INCREASED CHANCES OF RENAL STONE FORMATION
|
INCREASED CHANCES OF RENAL STONE FORMATION
|
CO-ADMINISTRATION CAN LEAD TO HIGH SERUM CONCENTRATION OF ACETAZOLAMIDE DUE TO COMPITITION AT RENAL TUBULES FOR SECRETION AND TOXICITY LEADING TO ANOREXIA,TACHYCARDIA,LETHARGYNESS,COMA & DEATH
|
CO-ADMINISTRATION CAN LEAD TO HIGH SERUM CONCENTRATION OF ACETAZOLAMIDE DUE TO COMPITITION AT RENAL TUBULES FOR SECRETION AND TOXICITY LEADING TO ANOREXIA,TACHYCARDIA,LETHARGYNESS,COMA & DEATH
|
CO-ADMINISTRATION CAN LEAD TO HIGH SERUM CONCENTRATION OF ACETAZOLAMIDE DUE TO COMPITITION AT RENAL TUBULES FOR SECRETION AND TOXICITY LEADING TO ANOREXIA,TACHYCARDIA,LETHARGYNESS,COMA & DEATH
|
CO-ADMINISTRATION CAN LEAD TO HIGH SERUM CONCENTRATION OF ACETAZOLAMIDE DUE TO COMPITITION AT RENAL TUBULES FOR SECRETION AND TOXICITY LEADING TO ANOREXIA,TACHYCARDIA,LETHARGYNESS,COMA & DEATH
|
CO-ADMINISTRATION CAN LEAD TO HIGH SERUM CONCENTRATION OF ACETAZOLAMIDE DUE TO COMPITITION AT RENAL TUBULES FOR SECRETION AND TOXICITY LEADING TO ANOREXIA,TACHYCARDIA,LETHARGYNESS,COMA & DEATH
|
CO-ADMINISTRATION CAN LEAD TO HIGH SERUM CONCENTRATION OF ACETAZOLAMIDE DUE TO COMPITITION AT RENAL TUBULES FOR SECRETION AND TOXICITY LEADING TO ANOREXIA,TACHYCARDIA,LETHARGYNESS,COMA & DEATH
|
CO-ADMINISTRATION CAN LEAD TO HIGH SERUM CONCENTRATION OF ACETAZOLAMIDE DUE TO COMPITITION AT RENAL TUBULES FOR SECRETION AND TOXICITY LEADING TO ANOREXIA,TACHYCARDIA,LETHARGYNESS,COMA & DEATH
|
CO-ADMINISTRATION CAN LEAD TO HIGH SERUM CONCENTRATION OF ACETAZOLAMIDE DUE TO COMPITITION AT RENAL TUBULES FOR SECRETION AND TOXICITY LEADING TO ANOREXIA,TACHYCARDIA,LETHARGYNESS,COMA & DEATH
|
CO-ADMINISTRATION CAN LEAD TO HIGH SERUM CONCENTRATION OF ACETAZOLAMIDE DUE TO COMPITITION AT RENAL TUBULES FOR SECRETION AND TOXICITY LEADING TO ANOREXIA,TACHYCARDIA,LETHARGYNESS,COMA & DEATH
|
CO-ADMINISTRATION CAN LEAD TO HIGH SERUM CONCENTRATION OF ACETAZOLAMIDE DUE TO COMPITITION AT RENAL TUBULES FOR SECRETION AND TOXICITY LEADING TO ANOREXIA,TACHYCARDIA,LETHARGYNESS,COMA & DEATH
|
CO-ADMINISTRATION CAN LEAD TO HIGH SERUM CONCENTRATION OF ACETAZOLAMIDE DUE TO COMPITITION AT RENAL TUBULES FOR SECRETION AND TOXICITY LEADING TO ANOREXIA,TACHYCARDIA,LETHARGYNESS,COMA & DEATH
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
THIAZIDE DIURETICS MAY CAUSE HYPERCALCAEMIA DUE TO DECREASED CALCIUM EXCRETION
|
THIAZIDE DIURETICS MAY CAUSE HYPERCALCAEMIA DUE TO DECREASED CALCIUM EXCRETION
|
THIAZIDE DIURETICS MAY CAUSE HYPERCALCAEMIA DUE TO DECREASED CALCIUM EXCRETION
|
THIAZIDE DIURETICS MAY CAUSE HYPERCALCAEMIA DUE TO DECREASED CALCIUM EXCRETION
|
CONCURRENT USE MAY CAUSE / POTENTIATE HYPOKALEMIA WHICH COULD PREDISPOSE THE PATIENT TO CARDIAC DYSFUNCTION
|
CONCURRENT USE MAY CAUSE / POTENTIATE HYPOKALEMIA WHICH COULD PREDISPOSE THE PATIENT TO CARDIAC DYSFUNCTION
|
CONCURRENT USE MAY CAUSE / POTENTIATE HYPOKALEMIA WHICH COULD PREDISPOSE THE PATIENT TO CARDIAC DYSFUNCTION
|
CONCURRENT USE MAY CAUSE / POTENTIATE HYPOKALEMIA WHICH COULD PREDISPOSE THE PATIENT TO CARDIAC DYSFUNCTION
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS DECREASE ITS URINARY EXCRETION LEADING TO HYPERCALCEMIA
|
THIAZIDE DIURETICS CONCOMITANT USE MAY LEAD TO HYPOCALCAEMIA
|
THIAZIDE DIURETICS CONCOMITANT USE MAY LEAD TO HYPOCALCAEMIA
|
THIAZIDE DIURETICS CONCOMITANT USE MAY LEAD TO HYPOCALCAEMIA
|
THIAZIDE DIURETICS CONCOMITANT USE MAY LEAD TO HYPOCALCAEMIA
|
THIAZIDE DIURETICS CONCOMITANT USE MAY LEAD TO HYPOCALCAEMIA
|
ACETAZOLAMIDE INHIBITS RENAL EXCRETION OF BASIC DRUGS LIKE AMPHETAMINES, QUINIDINE
|
ACETAZOLAMIDE INHIBITS RENAL EXCRETION OF BASIC DRUGS LIKE AMPHETAMINES, QUINIDINE
|
ACETAZOLAMIDE INHIBITS RENAL EXCRETION OF BASIC DRUGS LIKE AMPHETAMINES, QUINIDINE
|
ACETAZOLAMIDE INHIBITS RENAL EXCRETION OF BASIC DRUGS LIKE AMPHETAMINES, QUINIDINE
|
DIURETICS CAUSED HYPOKALEMIA MAY ANTAGONISE THE EFFECTS OF LIGNOCAIN
|
DIURETICS CAUSED HYPOKALEMIA MAY ANTAGONISE THE EFFECTS OF LIGNOCAIN
|
DIURETICS CAUSED HYPOKALEMIA MAY ANTAGONISE THE EFFECTS OF LIGNOCAIN
|
DIURETICS CAUSED HYPOKALEMIA MAY ANTAGONISE THE EFFECTS OF LIGNOCAIN
|
DIURETICS CAUSED HYPOKALEMIA MAY ANTAGONISE THE EFFECTS OF LIGNOCAIN
|
DIURETICS CAUSED HYPOKALEMIA MAY ANTAGONISE THE EFFECTS OF LIGNOCAIN
|
DIURETICS CAUSED HYPOKALEMIA MAY ANTAGONISE THE EFFECTS OF LIGNOCAIN
|
DIURETICS CAUSED HYPOKALEMIA MAY ANTAGONISE THE EFFECTS OF LIGNOCAIN
|
DIURETICS CAUSED HYPOKALEMIA MAY ANTAGONISE THE EFFECTS OF LIGNOCAIN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED RISK OF HYPOKALEMIA
|